FINWIRES · TerminalLIVE
FINWIRES

Urban Outfitters Delivered Solid Q2 but Lacks Catalysts to Re-Rate, UBS Says

By

Urban Outfitters (URBN) needs a clearer catalyst before its stock can re-rate, even after delivering solid double-digit top-line growth, UBS said in a note Thursday.

UBS said rising EPS estimates against a rangebound stock over the past five quarters are making the valuation increasingly attractive, but flagged two questions that needs answer to turn more positive.

The firm asked whether Urban Outfitters has structurally improved its ability to manage fashion risk, noting Anthropologie's quick rebound from execution issues in the prior two quarters, and whether the company's shared-services model is generating more synergies across brands than in the past, pointing to management's comments on AI as a source of innovation.

UBS said affirmative answers on either front, or fading risks around oil prices and tariffs, could make it more positive on the stock.

UBS maintained its neutral rating on the stock and raised the price target to $82 from $80.

Price: $79.52, Change: $-3.43, Percent Change: -4.14%

Related Articles

Wire

Update: Magellan Financial Group Fiscal 2026 Operating Earnings, Revenue Down; Shares Fall 12%

(Updates to add stock movement in the headline and the last paragraph)Magellan Financial Group (ASX:MFG) logged AU$0.828 in operating earnings per share for fiscal 2026, compared with AU$0.898 a year ago, a Thursday filing showed.For the 12 months ended June 30, revenue and other income was AU$195.6 million versus AU$318.9 million previously, the Australia-listed financial services firm added.The board declared a final dividend of AU$0.255 per share, payable Sept. 16 to shareholders on record as of Sept. 2. A year ago, the company paid a final dividend AU$0.259 per share and special dividend of AU$0.21 per share.The board has revised the group's dividend policy from fiscal 2027, targeting a payout ratio of 60% to 90% of operating profit after tax.The company's shares fell 12% in recent Thursday trade.

ASX:MFG
Wire

Tenable to Join S&P SmallCap 600 Index

Tenable (TENB) will join the S&P SmallCap 600 index before market open on Aug. 31, the S&P Dow Jones Indices said in a late Wednesday statement.Tenable will replace Leggett & Platt (LEG), which is being acquired by Somnigroup International (SGI), according to the statement.

$LEG$SGI$TENB
Wire

NeoGenomics Wins Expanded Medicare Coverage for RaDaR ST Immunotherapy Monitoring

NeoGenomics (NEO) said its RaDaR ST molecular residual disease assay received expanded Medicare coverage to include immunotherapy response monitoring for patients with late-stage solid tumors.The determination from the Centers for Medicare & Medicaid Services' Molecular Diagnostic Services Program is the third Medicare-covered indication for RaDaR ST, NeoGenomics said Wednesday in a statement.The coverage allows use of the assay to monitor response to immune-checkpoint inhibitor therapy, and NeoGenomics said it has two additional RaDaR ST submissions pending.NeoGenomics shares rose 2.1% in after-hours trading.

$NEO